Navigation Links
DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter

NEW YORK, July 10, 2012 /PRNewswire/ -- Legal-Bay LLC, the lawsuit settlement funding company, announced today that the company had a robust 2nd quarter mostly due to high volume in assisting victims with pre-settlement funding of the DePuy and Johnson & Johnson Hip Implant Recall, as well as Transvaginal Mesh products.  Additionally, the company expanded its operations to a new "state of the art" facility with increased staff, additional funding capital, and newly aligned marketing partners. 

The sales of both DePuy and the various mesh cases (vaginal, pelvic, bladder slings, and hernia Kugel mesh) were due to both of the litigations slowing down without any settlement news.  However, Legal-Bay believes that the average settlement value for both DePuy and transvaginal mesh cases could be from $500K to $1mm depending on damages and other factors.  Legal-Bay provides individuals with what plaintiff's refer to as "lawsuit loans" with up to $50K on each of these cases.  However, the lawsuit cash advance is not a lawsuit loan and only needs to be paid back if the case is actually won. 

Patty Kirby, Head of Client Relations, commented about the company's success, "Most of our DePuy lawsuit funding and Mesh clients cannot wait and need money today, so our program enables them to access $50K immediately off their case and still be left with approximately $450K at settlement on a case valued at $500K. The 2nd quarter our applications were up across the board, as we have recently launched a separate division for accident lawsuit funding cases.  We added staff to handle this influx of business.  We are now equipped to handle the largest funding cases with extremely low rates and the absolute fastest turnaround time's industry wide."

Legal-Bay says that they have also seen substantial growth in Commercial Litigation, Quit Tam or Whistleblower, Wrongful Imprisonment, FELA, Jones Act, Mesothelioma, and Actos Pharmaceutical case funding in 2012. 

Plaintiffs in need of a DePuy, Transvaginal Mesh lawsuit funding, car or commercial truck accident funding or any other lawsuit settlement funding can apply directly to or call toll free at 877.571.0405 where agents are standing by 24 hours a day to assist you. 

Contact:  Patty Kirby, Head of Client Relations, ph. 877.571.0405

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
3. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
4. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
5. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
8. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
9. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
10. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
11. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
Post Your Comments:
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
Breaking Medicine News(10 mins):